A data repository for HIV pharmacology
HIV Pharmacology Data Repository
This study is working to gather and organize a huge amount of information about HIV treatments to help researchers find better ways to help patients like you, making it easier for them to discover new and improved treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11010806 on NIH RePORTER |
What this research studies
This research focuses on creating a comprehensive data repository that consolidates pharmacological data related to HIV treatment and prevention. It aims to enhance the accessibility and usability of over 75,000 unique data points from various studies, which quantify the effects of antiretroviral drugs. By applying principles that ensure the data is findable, accessible, interoperable, and reusable, the project seeks to facilitate biomedical research and accelerate the discovery of new therapeutic strategies for HIV. Patients may benefit from improved treatment options as researchers utilize this data to inform their studies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals living with HIV or those at high risk of HIV infection.
Not a fit: Patients who are not affected by HIV or are not at risk for HIV infection may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective HIV treatments and prevention strategies.
How similar studies have performed: Other research initiatives utilizing data repositories for pharmacological data have shown success in advancing treatment options, indicating that this approach is promising.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Cottrell, Mackenzie — Univ of North Carolina Chapel Hill
- Study coordinator: Cottrell, Mackenzie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.